OR WAIT null SECS
Jürgen Floege, MD, senior professor at RWTH Aachen University’s Medical School
November 20, 2025
Video
ASN insights on felzartamab, a CD38-targeted therapy, show sustained immune modulation in IgA nephropathy, offering a novel treatment approach.